Increased relative biological effectiveness and periventricular radiosensitivity in proton therapy of glioma patients.

Publikation

Increased relative biological effectiveness and periventricular radiosensitivity in proton therapy of glioma patients.

Wissenschaftlicher Artikel/Review - 23.11.2022

Eulitz Jan, Troost Esther G C, Klünder Lauritz, Raschke Felix, Hahn Christian, Schulz Erik, Seidlitz Annekatrin, Thiem Justus, Karpowitz Caroline, Hahlbohm Patricia, Grey Arne, Engellandt Kay, Löck Steffen, Krause Mechthild, Lühr Armin

Zitation

Eulitz J, Troost E, Klünder L, Raschke F, Hahn C, Schulz E, Seidlitz A, Thiem J, Karpowitz C, Hahlbohm P, Grey A, Engellandt K, Löck S, Krause M, Lühr A. Increased relative biological effectiveness and periventricular radiosensitivity in proton therapy of glioma patients. Radiother Oncol 2022; 178:109422.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Radiother Oncol 2022; 178

Veröffentlichungsdatum

23.11.2022

eISSN (Online)

1879-0887

Seiten

109422

Kurzbeschreibung/Zielsetzung

Currently, there is an intense debate on variations in intra-cerebral radiosensitivity and relative biological effectiveness (RBE) in proton therapy of primary brain tumours. Here, both effects were retrospectively investigated using late radiation-induced brain injuries (RIBI) observed in follow-up after proton therapy of patients with diagnosed glioma.